Concepedia

Kelly C. Goldsmith

KC

Statistics

Publications

32

Citations

1.5K

H-Index

24

Active since

2004

Affiliations

Children's Healthcare of Atlanta(Current)

Emory University

Children's Hospital of Philadelphia

Aflac (United States)

University of Pennsylvania

Kelly C. Goldsmith is an author at Children's Healthcare of Atlanta specializing in oncology, medicine, and neuroblastoma biology.

ORCID

Publications per year

2004–2023

32

Publications

32

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser et al. · Nature Medicine · 2023 · 125 citations · Full text

, , +10

Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma

Victor Maximov, Zhihong Chen, Yun Wei et al. · Nature Communications · 2019 · 110 citations · Full text

, , +17

Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists

Brian Lestini, Kelly C. Goldsmith, Mark Fluchel et al. · Cancer Biology & Therapy · 2009 · 92 citations · Full text

, , +17

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)

David T. Teachey, Dana Obzut, Kelly Axsom et al. · Blood · 2006 · 89 citations · Full text

, , +10

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Steven G. DuBois, Yaël P. Mossé, Elizabeth Fox et al. · Clinical Cancer Research · 2018 · 88 citations

, , +8

1–5 of 32